{"data":[{"accessionNo":"0001385702-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"MAK Capital Fund LP","reportingCik":null,"personType":"PN","sharesOwned":28813904,"percentOfClass":7.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001385702-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"Kaufman Michael A","reportingCik":null,"personType":"IN","sharesOwned":28813904,"percentOfClass":7.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001385702-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-06-30","reportingPerson":"MAK CAPITAL ONE LLC","reportingCik":null,"personType":"IA","sharesOwned":28813904,"percentOfClass":7.3,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001019056-26-000130","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"JOHN HELMERS","reportingCik":null,"personType":"IN","sharesOwned":23500000,"percentOfClass":6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001019056-26-000130","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"LONG FOCUS CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"IA","sharesOwned":23500000,"percentOfClass":6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0002012383-26-003074","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":7911347,"percentOfClass":2,"filedAt":"2026-07-30","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Shabet Rose Sharon","reportingCik":null,"personType":"IN","sharesOwned":58651170,"percentOfClass":15,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"HALVORSEN OLE ANDREAS","reportingCik":null,"personType":"IN","sharesOwned":58651170,"percentOfClass":15,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"VIKING GLOBAL INVESTORS LP","reportingCik":"0001103804","personType":"PN","sharesOwned":58651170,"percentOfClass":15,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Viking Global Opportunities Parent GP LLC","reportingCik":null,"personType":"OO","sharesOwned":58651170,"percentOfClass":15,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Viking Global Opportunities Illiquid Investments Sub-Master LP","reportingCik":null,"personType":"PN","sharesOwned":39296310,"percentOfClass":10.1,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Viking Global Opportunities Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":39296310,"percentOfClass":10.1,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Viking Global Opportunities GP LLC","reportingCik":null,"personType":"OO","sharesOwned":39296310,"percentOfClass":10.1,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Viking Global Opportunities Drawdown Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":19354860,"percentOfClass":5,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Viking Global Opportunities Drawdown (Aggregator) LP","reportingCik":null,"personType":"PN","sharesOwned":19354860,"percentOfClass":5,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002940","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Viking Global Opportunities Drawdown GP LLC","reportingCik":null,"personType":"OO","sharesOwned":19354860,"percentOfClass":5,"filedAt":"2026-06-12","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-26-003923","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Eli Casdin","reportingCik":"0001534264","personType":"IN,HC","sharesOwned":93845778,"percentOfClass":23.9,"filedAt":"2026-06-09","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-26-003923","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Casdin Capital, LLC","reportingCik":"0001534261","personType":"IA","sharesOwned":88783856,"percentOfClass":22.7,"filedAt":"2026-06-09","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-26-003923","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Casdin Partners GP, LLC","reportingCik":"0001534260","personType":"OO","sharesOwned":72100000,"percentOfClass":18.5,"filedAt":"2026-06-09","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-26-003923","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Casdin Partners Master Fund, L.P.","reportingCik":"0001534265","personType":"PN","sharesOwned":72100000,"percentOfClass":18.5,"filedAt":"2026-06-09","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-26-003923","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Casdin Private Growth Equity Fund II, L.P.","reportingCik":"0001891102","personType":"PN","sharesOwned":13939637,"percentOfClass":3.6,"filedAt":"2026-06-09","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-26-003923","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-06","reportingPerson":"Casdin Private Growth Equity Fund II GP, LLC","reportingCik":"0001919480","personType":"OO","sharesOwned":13939637,"percentOfClass":3.6,"filedAt":"2026-06-09","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Shabet Rose Sharon","reportingCik":null,"personType":"IN","sharesOwned":58651170,"percentOfClass":15,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"HALVORSEN OLE ANDREAS","reportingCik":null,"personType":"IN","sharesOwned":58651170,"percentOfClass":15,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"VIKING GLOBAL INVESTORS LP","reportingCik":null,"personType":"PN","sharesOwned":58651170,"percentOfClass":15,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Parent GP LLC","reportingCik":null,"personType":"OO","sharesOwned":58651170,"percentOfClass":15,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Illiquid Investments Sub-Master LP","reportingCik":null,"personType":"PN","sharesOwned":39296310,"percentOfClass":10.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":39296310,"percentOfClass":10.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities GP LLC","reportingCik":null,"personType":"OO","sharesOwned":39296310,"percentOfClass":10.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001426156-26-000013","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"MAK Capital Fund LP","reportingCik":null,"personType":"PN","sharesOwned":26172626,"percentOfClass":6.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001426156-26-000013","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Michael A. Kaufman","reportingCik":null,"personType":"IN","sharesOwned":26172626,"percentOfClass":6.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001426156-26-000013","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"MAK Capital One L.L.C.","reportingCik":null,"personType":"IA","sharesOwned":26172626,"percentOfClass":6.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Drawdown Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":19354860,"percentOfClass":5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Drawdown (Aggregator) LP","reportingCik":null,"personType":"PN","sharesOwned":19354860,"percentOfClass":5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000905148-26-002428","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":"34385P108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Drawdown GP LLC","reportingCik":null,"personType":"OO","sharesOwned":19354860,"percentOfClass":5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001019056-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"MAK Capital Fund LP","reportingCik":null,"personType":"PN","sharesOwned":19967565,"percentOfClass":5.19,"filedAt":"2026-01-07","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001019056-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"MAK Capital One L.L.C.","reportingCik":null,"personType":"IA","sharesOwned":19967565,"percentOfClass":5.19,"filedAt":"2026-01-07","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0001019056-26-000002","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001162194","issuerName":"STANDARD BIOTOOLS INC.","ticker":"LAB","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Michael A. Kaufman","reportingCik":null,"personType":"IN","sharesOwned":19967565,"percentOfClass":5.19,"filedAt":"2026-01-07","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-25-007210","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-25","reportingPerson":"Eli Casdin","reportingCik":"0001534264","personType":"IN,HC","sharesOwned":93442787,"percentOfClass":24.2,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-25-007210","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-25","reportingPerson":"Casdin Capital, LLC","reportingCik":"0001534261","personType":"IA","sharesOwned":88433856,"percentOfClass":22.9,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-25-007210","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-25","reportingPerson":"Casdin Partners Master Fund, L.P.","reportingCik":"0001534265","personType":"PN","sharesOwned":71750000,"percentOfClass":18.7,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-25-007210","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-25","reportingPerson":"Casdin Partners GP, LLC","reportingCik":"0001534260","personType":"OO","sharesOwned":71750000,"percentOfClass":18.7,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-25-007210","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-25","reportingPerson":"Casdin Private Growth Equity Fund II, L.P.","reportingCik":"0001891102","personType":"PN","sharesOwned":13939637,"percentOfClass":3.6,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/lab"},{"accessionNo":"0000919574-25-007210","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0001162194","issuerName":"Standard BioTools Inc.","ticker":"LAB","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-25","reportingPerson":"Casdin Private Growth Equity Fund II GP, LLC","reportingCik":"0001919480","personType":"OO","sharesOwned":13939637,"percentOfClass":3.6,"filedAt":"2025-11-28","canonicalUrl":"https://xoomar.com/markets/stocks/lab"}],"updatedAt":"2026-10-24T18:59:20.696Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/lab","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}